13 research outputs found
Le questionnaire de Santé (support d'un examen de santé en secteur libéral)
En France, certains organismes d Assurance Maladie coordonnent des examens de santĂ© en secteur libĂ©ral basĂ©s sur un questionnaire de santĂ©. Aucune Ă©tude relative Ă l opinion des mĂ©decins gĂ©nĂ©ralistes sur ces outils de prĂ©vention n a Ă©tĂ© publiĂ©e, alors qu ils sont les principaux acteurs. Objectif : Recueillir l opinion des mĂ©decins gĂ©nĂ©ralistes de Haute-Vienne sur ces questionnaires et examens de santĂ©. MatĂ©riel et mĂ©thodes : RĂ©alisation d une Ă©tude descriptive, Ă partir d un questionnaire envoyĂ© aux 460 mĂ©decins gĂ©nĂ©ralistes installĂ©s en Haute-Vienne, en novembre 2007. Il comportait 29 questions portant sur leur investissement dans ces examens de santĂ©, leur intĂ©rĂȘt pour les questionnaires de santĂ© et leurs propositions. RĂ©sultats : Le taux de rĂ©ponses exploitables a Ă©tĂ© de 43,73 %, montrant une volontĂ© des gĂ©nĂ©ralistes de donner leur opinion. Bien que conscients de leur rĂŽle dans la prĂ©vention, les mĂ©decins interrogĂ©s ont montrĂ© un intĂ©rĂȘt mitigĂ© pour ces questionnaires de santĂ© et la perspective de leur gĂ©nĂ©ralisation. MĂȘme si certains d entre eux sont rĂ©ticents aux initiatives publiques, une majoritĂ© a souhaitĂ© que l Assurance Maladie coordonne ces examens. Le manque de temps des gĂ©nĂ©ralistes, et la redondance par rapport aux consultations habituelles, liĂ©e Ă l absence de ciblage des patients peu suivis mĂ©dicalement, sont les freins majeurs Ă la rĂ©ussite de ces projets. Conclusion : Les mĂ©decins gĂ©nĂ©ralistes ne veulent pas ĂȘtre les seuls acteurs de prĂ©vention. Cependant, de tels projets ne pourront ĂȘtre efficients que si l on tient compte de leur opinion. Enfin, une formation des gĂ©nĂ©ralistes Ă la prĂ©vention et Ă la dĂ©marche de santĂ© publique semble nĂ©cessaire.LIMOGES-BU MĂ©decine pharmacie (870852108) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
Comment les médecins généralistes installés en Limousin ont envisagé l'évolution de leur exercice ? (étude qualitative en Limousin en 2011)
LIMOGES-BU MĂ©decine pharmacie (870852108) / SudocSudocFranceF
HygiÚne au cabinet médical (audit de pratique auprÚs des médecins généralistes du Limousin)
LIMOGES-BU MĂ©decine pharmacie (870852108) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
La prise en charge de l'obésité (attitudes et pratiques des médecins généralistes en Haute-Vienne)
LIMOGES-BU MĂ©decine pharmacie (870852108) / SudocSudocFranceF
Les structures d'aide au maintien à domicile chez les patients déments (une étude observationnelle chez les médecins généralistes en Haute-Vienne en 2011)
LIMOGES-BU MĂ©decine pharmacie (870852108) / SudocSudocFranceF
Signes évocateurs d'un syndrome de Lasthénie de Ferjol en présence d'une anémie ferriprive inexpliquée
LIMOGES-BU MĂ©decine pharmacie (870852108) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
Contraception (que croient savoir et que savent réellement les femmes ?)
LIMOGES-BU MĂ©decine pharmacie (870852108) / SudocSudocFranceF
Signes évocateurs d'un syndrome de Lasthénie de Ferjol en présence d'une anémie ferriprive inexpliquée
LIMOGES-BU MĂ©decine pharmacie (870852108) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
Describing perceived stigma against Alzheimer's disease in a general population in France: the STIG-MA survey
International audienceBackgroundAlzheimer's disease (AD) causes progressive loss of memory and disability, especially in older people. As worldwide population grows older, AD is responsible for an important social and economical burden in many nations. People suffering from AD may experience healthârelated stigma that influences their attitudes towards seeking assistance. The STIGâMA survey describes perceived stigma against AD in a French population.MethodsThe STIGâMA questionnaire was completed anonymously by people attending an awareness campaign about AD in Creuse, France, in September 2010. Participants answered 10 questions about how they would feel or react if they had AD. Stigma scores were compared by age, activity, and interest in AD.ResultsThirtyâthree percent of people attending the campaign filled out the survey. Most were women (85%) younger than 50âyears (59%); 10% were older people (older than 75âyears). Twentyâone percent worked in health or social fields. Interest in AD was professional (48%), related to family (41%), or personal (11%). Professionals in health fields expressed the highest levels of stigma (pâ=â0.02). Low stigma was most frequent in older people (pâ=â0.05). Type of interest did not influence stigma. Shame, loss of selfâesteem, and fear of exclusion were expressed the most.ConclusionThe STIGâMA survey confirms that AD is a stigmatizing condition in France. The difference between perceived stigma of older people, those most exposed to AD, and that of health professionals may influence attitudes towards screening and care. Further studies of perceived stigma in these populations are necessary to adapt intervention strategies
A prospective study to evaluate the contribution of the pediatric appendicitis score in the decision process
Abstract Background The objective of this study was to assess the likelihood of acute appendicitis (AA) in children presenting with abdominal symptoms at the emergency department (ED), based on their prior primary care (PC) consultation history. Methods Between February and June 2021, we prospectively enrolled all children presenting at the ED with acute abdominal pain indicative of possible acute appendicitis (AA). Subsequently, they were categorized into three groups: those assessed by a PC physician (PG), those brought in by their family without a prior consultation (FG), and those admitted after a PC consultation without being assessed as such. The primary objective was to assess the probability of AA diagnosis using the Pediatric Appendicitis Score (PAS). Secondary objectives included analyzing PAS and C-reactive protein (CRP) levels based on the duration of pain and final diagnoses. Results 124 children were enrolled in the study (PG, nâ=â56; FG, nâ=â55; NG, nâ=â13). Among them, 29 patients (23.4%) were diagnosed with AA, with 13 cases (23.2%) from the PG and 14 cases (25.4%) from the FG. The mean PAS scores for AA cases from the PG and FG were 6.69 ± 1.75 and 7.57 ± 1.6, respectively, (pâ=â0.3340). Both PAS scores and CRP levels showed a significant correlation with AA severity. No cases of AA were observed with PAS scoresâ<â4. Conclusions There was no significant difference in PAS scores between patients addressed by PG and FG, even though PAS scores tended to be higher for patients with AA. We propose a new decision-making algorithm for PC practice, which incorporates inflammatory markers and pain duration. Trial registration Institutional Ethics Committee registration number: 447-2021-103 (10/01/2021). Clinical trials registration number ClinicalTrials.gov Identifier: NCT04885335 (Registered on 13/05/2021)